Global Image-Guided Biopsy Market by Process (Fine Needles, Core Needles, Vacuum-assisted Biopsy), by End User (Ambulatory Surgery Centers, Clinics, Academic Institutes, Research, Hospitals), by Technology (X- Ray, CT, MRI, Ultrasound, Mammography) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028
Up Market Research published a new report titled “Image-Guided Biopsy Market research report which is segmented by Process (Fine Needles, Core Needles, Vacuum-assisted Biopsy), by End User (Ambulatory Surgery Centers, Clinics, Academic Institutes, Research, Hospitals), by Technology (X- Ray, CT, MRI, Ultrasound, Mammography), By Players/Companies Medtronic, Varian Medical Systems Inc., Analogic Corporation, KARL STORZ Endoscopy India Pvt. Ltd., Brainlab, Siemens Healthcare GmbH, Olympus Corporation, GENERAL ELECTRIC, Hologic Inc., Koninklijke Philips N.V., Stryker”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Scope
| Report Attributes | Report Details |
| Report Title | Image-Guided Biopsy Market Research Report |
| By Process | Fine Needles, Core Needles, Vacuum-assisted Biopsy |
| By End User | Ambulatory Surgery Centers, Clinics, Academic Institutes, Research, Hospitals |
| By Technology | X- Ray, CT, MRI, Ultrasound, Mammography |
| By Companies | Medtronic, Varian Medical Systems Inc., Analogic Corporation, KARL STORZ Endoscopy India Pvt. Ltd., Brainlab, Siemens Healthcare GmbH, Olympus Corporation, GENERAL ELECTRIC, Hologic Inc., Koninklijke Philips N.V., Stryker |
| Regions Covered | North America, Europe, APAC, Latin America, MEA |
| Base Year | 2020 |
| Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
| Forecast Year | 2028 |
| Number of Pages | 219 |
| Number of Tables & Figures | 154 |
| Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Global Image-Guided Biopsy Market Report Segments:
The market is segmented by Process (Fine Needles, Core Needles, Vacuum-assisted Biopsy), by End User (Ambulatory Surgery Centers, Clinics, Academic Institutes, Research, Hospitals), by Technology (X- Ray, CT, MRI, Ultrasound, Mammography).
Image-Guided Biopsy Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Image-Guided Biopsy Market
Overview of the regional outlook of the Image-Guided Biopsy Market:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
Highlights of The Image-Guided Biopsy Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of Image-Guided Biopsy Market.
- Historical data and forecast.
- Estimations for the forecast period 2028.
- Developments and trends in the market.
1. Fine Needles
2. Core Needles
3. Vacuum-assisted Biopsy
7. By End User:1. Ambulatory Surgery Centers
2. Clinics
3. Academic Institutes
4. Research
5. Hospitals
8. By Technology:1. X- Ray
2. CT
3. MRI
4. Ultrasound
5. Mammography
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Image-Guided Biopsy Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
Reasons to Purchase the Image-Guided Biopsy Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Image-Guided Biopsy Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Image-Guided Biopsy Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Image-Guided Biopsy Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Image-Guided Biopsy Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Image-Guided Biopsy Market Size & Forecast, 2018-2028
4.5.1 Image-Guided Biopsy Market Size and Y-o-Y Growth
4.5.2 Image-Guided Biopsy Market Absolute $ Opportunity
Chapter 5 Global Image-Guided Biopsy Market Analysis and Forecast by Process
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Process
5.1.2 Basis Point Share (BPS) Analysis by Process
5.1.3 Absolute $ Opportunity Assessment by Process
5.2 Image-Guided Biopsy Market Size Forecast by Process
5.2.1 Fine Needles
5.2.2 Core Needles
5.2.3 Vacuum-assisted Biopsy
5.3 Market Attractiveness Analysis by Process
Chapter 6 Global Image-Guided Biopsy Market Analysis and Forecast by End User
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by End User
6.1.2 Basis Point Share (BPS) Analysis by End User
6.1.3 Absolute $ Opportunity Assessment by End User
6.2 Image-Guided Biopsy Market Size Forecast by End User
6.2.1 Ambulatory Surgery Centers
6.2.2 Clinics
6.2.3 Academic Institutes
6.2.4 Research
6.2.5 Hospitals
6.3 Market Attractiveness Analysis by End User
Chapter 7 Global Image-Guided Biopsy Market Analysis and Forecast by Technology
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Technology
7.1.2 Basis Point Share (BPS) Analysis by Technology
7.1.3 Absolute $ Opportunity Assessment by Technology
7.2 Image-Guided Biopsy Market Size Forecast by Technology
7.2.1 X- Ray
7.2.2 CT
7.2.3 MRI
7.2.4 Ultrasound
7.2.5 Mammography
7.3 Market Attractiveness Analysis by Technology
Chapter 8 Global Image-Guided Biopsy Market Analysis and Forecast by Region
8.1 Introduction
8.1.1 Key Market Trends & Growth Opportunities by Region
8.1.2 Basis Point Share (BPS) Analysis by Region
8.1.3 Absolute $ Opportunity Assessment by Region
8.2 Image-Guided Biopsy Market Size Forecast by Region
8.2.1 North America
8.2.2 Europe
8.2.3 Asia Pacific
8.2.4 Latin America
8.2.5 Middle East & Africa (MEA)
8.3 Market Attractiveness Analysis by Region
Chapter 9 Coronavirus Disease (COVID-19) Impact
9.1 Introduction
9.2 Current & Future Impact Analysis
9.3 Economic Impact Analysis
9.4 Government Policies
9.5 Investment Scenario
Chapter 10 North America Image-Guided Biopsy Analysis and Forecast
10.1 Introduction
10.2 North America Image-Guided Biopsy Market Size Forecast by Country
10.2.1 U.S.
10.2.2 Canada
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 North America Image-Guided Biopsy Market Size Forecast by Process
10.6.1 Fine Needles
10.6.2 Core Needles
10.6.3 Vacuum-assisted Biopsy
10.7 Basis Point Share (BPS) Analysis by Process
10.8 Absolute $ Opportunity Assessment by Process
10.9 Market Attractiveness Analysis by Process
10.10 North America Image-Guided Biopsy Market Size Forecast by End User
10.10.1 Ambulatory Surgery Centers
10.10.2 Clinics
10.10.3 Academic Institutes
10.10.4 Research
10.10.5 Hospitals
10.11 Basis Point Share (BPS) Analysis by End User
10.12 Absolute $ Opportunity Assessment by End User
10.13 Market Attractiveness Analysis by End User
10.14 North America Image-Guided Biopsy Market Size Forecast by Technology
10.14.1 X- Ray
10.14.2 CT
10.14.3 MRI
10.14.4 Ultrasound
10.14.5 Mammography
10.15 Basis Point Share (BPS) Analysis by Technology
10.16 Absolute $ Opportunity Assessment by Technology
10.17 Market Attractiveness Analysis by Technology
Chapter 11 Europe Image-Guided Biopsy Analysis and Forecast
11.1 Introduction
11.2 Europe Image-Guided Biopsy Market Size Forecast by Country
11.2.1 Germany
11.2.2 France
11.2.3 Italy
11.2.4 U.K.
11.2.5 Spain
11.2.6 Russia
11.2.7 Rest of Europe
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Europe Image-Guided Biopsy Market Size Forecast by Process
11.6.1 Fine Needles
11.6.2 Core Needles
11.6.3 Vacuum-assisted Biopsy
11.7 Basis Point Share (BPS) Analysis by Process
11.8 Absolute $ Opportunity Assessment by Process
11.9 Market Attractiveness Analysis by Process
11.10 Europe Image-Guided Biopsy Market Size Forecast by End User
11.10.1 Ambulatory Surgery Centers
11.10.2 Clinics
11.10.3 Academic Institutes
11.10.4 Research
11.10.5 Hospitals
11.11 Basis Point Share (BPS) Analysis by End User
11.12 Absolute $ Opportunity Assessment by End User
11.13 Market Attractiveness Analysis by End User
11.14 Europe Image-Guided Biopsy Market Size Forecast by Technology
11.14.1 X- Ray
11.14.2 CT
11.14.3 MRI
11.14.4 Ultrasound
11.14.5 Mammography
11.15 Basis Point Share (BPS) Analysis by Technology
11.16 Absolute $ Opportunity Assessment by Technology
11.17 Market Attractiveness Analysis by Technology
Chapter 12 Asia Pacific Image-Guided Biopsy Analysis and Forecast
12.1 Introduction
12.2 Asia Pacific Image-Guided Biopsy Market Size Forecast by Country
12.2.1 China
12.2.2 Japan
12.2.3 South Korea
12.2.4 India
12.2.5 Australia
12.2.6 South East Asia (SEA)
12.2.7 Rest of Asia Pacific (APAC)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Asia Pacific Image-Guided Biopsy Market Size Forecast by Process
12.6.1 Fine Needles
12.6.2 Core Needles
12.6.3 Vacuum-assisted Biopsy
12.7 Basis Point Share (BPS) Analysis by Process
12.8 Absolute $ Opportunity Assessment by Process
12.9 Market Attractiveness Analysis by Process
12.10 Asia Pacific Image-Guided Biopsy Market Size Forecast by End User
12.10.1 Ambulatory Surgery Centers
12.10.2 Clinics
12.10.3 Academic Institutes
12.10.4 Research
12.10.5 Hospitals
12.11 Basis Point Share (BPS) Analysis by End User
12.12 Absolute $ Opportunity Assessment by End User
12.13 Market Attractiveness Analysis by End User
12.14 Asia Pacific Image-Guided Biopsy Market Size Forecast by Technology
12.14.1 X- Ray
12.14.2 CT
12.14.3 MRI
12.14.4 Ultrasound
12.14.5 Mammography
12.15 Basis Point Share (BPS) Analysis by Technology
12.16 Absolute $ Opportunity Assessment by Technology
12.17 Market Attractiveness Analysis by Technology
Chapter 13 Latin America Image-Guided Biopsy Analysis and Forecast
13.1 Introduction
13.2 Latin America Image-Guided Biopsy Market Size Forecast by Country
13.2.1 Brazil
13.2.2 Mexico
13.2.3 Rest of Latin America (LATAM)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Latin America Image-Guided Biopsy Market Size Forecast by Process
13.6.1 Fine Needles
13.6.2 Core Needles
13.6.3 Vacuum-assisted Biopsy
13.7 Basis Point Share (BPS) Analysis by Process
13.8 Absolute $ Opportunity Assessment by Process
13.9 Market Attractiveness Analysis by Process
13.10 Latin America Image-Guided Biopsy Market Size Forecast by End User
13.10.1 Ambulatory Surgery Centers
13.10.2 Clinics
13.10.3 Academic Institutes
13.10.4 Research
13.10.5 Hospitals
13.11 Basis Point Share (BPS) Analysis by End User
13.12 Absolute $ Opportunity Assessment by End User
13.13 Market Attractiveness Analysis by End User
13.14 Latin America Image-Guided Biopsy Market Size Forecast by Technology
13.14.1 X- Ray
13.14.2 CT
13.14.3 MRI
13.14.4 Ultrasound
13.14.5 Mammography
13.15 Basis Point Share (BPS) Analysis by Technology
13.16 Absolute $ Opportunity Assessment by Technology
13.17 Market Attractiveness Analysis by Technology
Chapter 14 Middle East & Africa (MEA) Image-Guided Biopsy Analysis and Forecast
14.1 Introduction
14.2 Middle East & Africa (MEA) Image-Guided Biopsy Market Size Forecast by Country
14.2.1 Saudi Arabia
14.2.2 South Africa
14.2.3 UAE
14.2.4 Rest of Middle East & Africa (MEA)
14.3 Basis Point Share (BPS) Analysis by Country
14.4 Absolute $ Opportunity Assessment by Country
14.5 Market Attractiveness Analysis by Country
14.6 Middle East & Africa (MEA) Image-Guided Biopsy Market Size Forecast by Process
14.6.1 Fine Needles
14.6.2 Core Needles
14.6.3 Vacuum-assisted Biopsy
14.7 Basis Point Share (BPS) Analysis by Process
14.8 Absolute $ Opportunity Assessment by Process
14.9 Market Attractiveness Analysis by Process
14.10 Middle East & Africa (MEA) Image-Guided Biopsy Market Size Forecast by End User
14.10.1 Ambulatory Surgery Centers
14.10.2 Clinics
14.10.3 Academic Institutes
14.10.4 Research
14.10.5 Hospitals
14.11 Basis Point Share (BPS) Analysis by End User
14.12 Absolute $ Opportunity Assessment by End User
14.13 Market Attractiveness Analysis by End User
14.14 Middle East & Africa (MEA) Image-Guided Biopsy Market Size Forecast by Technology
14.14.1 X- Ray
14.14.2 CT
14.14.3 MRI
14.14.4 Ultrasound
14.14.5 Mammography
14.15 Basis Point Share (BPS) Analysis by Technology
14.16 Absolute $ Opportunity Assessment by Technology
14.17 Market Attractiveness Analysis by Technology
Chapter 15 Competition Landscape
15.1 Image-Guided Biopsy Market: Competitive Dashboard
15.2 Global Image-Guided Biopsy Market: Market Share Analysis, 2019
15.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
15.3.1 Medtronic
15.3.2 Varian Medical Systems Inc.
15.3.3 Analogic Corporation
15.3.4 KARL STORZ Endoscopy India Pvt. Ltd.
15.3.5 Brainlab
15.3.6 Siemens Healthcare GmbH
15.3.7 Olympus Corporation
15.3.8 GENERAL ELECTRIC
15.3.9 Hologic Inc.
15.3.10 Koninklijke Philips N.V.
15.3.11 Stryker
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Image-Guided Biopsy Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Image-Guided Biopsy Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Image-Guided Biopsy Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Image-Guided Biopsy Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Image-Guided Biopsy Market Size & Forecast, 2018-2028
4.5.1 Image-Guided Biopsy Market Size and Y-o-Y Growth
4.5.2 Image-Guided Biopsy Market Absolute $ Opportunity
Chapter 5 Global Image-Guided Biopsy Market Analysis and Forecast by Process
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Process
5.1.2 Basis Point Share (BPS) Analysis by Process
5.1.3 Absolute $ Opportunity Assessment by Process
5.2 Image-Guided Biopsy Market Size Forecast by Process
5.2.1 Fine Needles
5.2.2 Core Needles
5.2.3 Vacuum-assisted Biopsy
5.3 Market Attractiveness Analysis by Process
Chapter 6 Global Image-Guided Biopsy Market Analysis and Forecast by End User
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by End User
6.1.2 Basis Point Share (BPS) Analysis by End User
6.1.3 Absolute $ Opportunity Assessment by End User
6.2 Image-Guided Biopsy Market Size Forecast by End User
6.2.1 Ambulatory Surgery Centers
6.2.2 Clinics
6.2.3 Academic Institutes
6.2.4 Research
6.2.5 Hospitals
6.3 Market Attractiveness Analysis by End User
Chapter 7 Global Image-Guided Biopsy Market Analysis and Forecast by Technology
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Technology
7.1.2 Basis Point Share (BPS) Analysis by Technology
7.1.3 Absolute $ Opportunity Assessment by Technology
7.2 Image-Guided Biopsy Market Size Forecast by Technology
7.2.1 X- Ray
7.2.2 CT
7.2.3 MRI
7.2.4 Ultrasound
7.2.5 Mammography
7.3 Market Attractiveness Analysis by Technology
Chapter 8 Global Image-Guided Biopsy Market Analysis and Forecast by Region
8.1 Introduction
8.1.1 Key Market Trends & Growth Opportunities by Region
8.1.2 Basis Point Share (BPS) Analysis by Region
8.1.3 Absolute $ Opportunity Assessment by Region
8.2 Image-Guided Biopsy Market Size Forecast by Region
8.2.1 North America
8.2.2 Europe
8.2.3 Asia Pacific
8.2.4 Latin America
8.2.5 Middle East & Africa (MEA)
8.3 Market Attractiveness Analysis by Region
Chapter 9 Coronavirus Disease (COVID-19) Impact
9.1 Introduction
9.2 Current & Future Impact Analysis
9.3 Economic Impact Analysis
9.4 Government Policies
9.5 Investment Scenario
Chapter 10 North America Image-Guided Biopsy Analysis and Forecast
10.1 Introduction
10.2 North America Image-Guided Biopsy Market Size Forecast by Country
10.2.1 U.S.
10.2.2 Canada
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 North America Image-Guided Biopsy Market Size Forecast by Process
10.6.1 Fine Needles
10.6.2 Core Needles
10.6.3 Vacuum-assisted Biopsy
10.7 Basis Point Share (BPS) Analysis by Process
10.8 Absolute $ Opportunity Assessment by Process
10.9 Market Attractiveness Analysis by Process
10.10 North America Image-Guided Biopsy Market Size Forecast by End User
10.10.1 Ambulatory Surgery Centers
10.10.2 Clinics
10.10.3 Academic Institutes
10.10.4 Research
10.10.5 Hospitals
10.11 Basis Point Share (BPS) Analysis by End User
10.12 Absolute $ Opportunity Assessment by End User
10.13 Market Attractiveness Analysis by End User
10.14 North America Image-Guided Biopsy Market Size Forecast by Technology
10.14.1 X- Ray
10.14.2 CT
10.14.3 MRI
10.14.4 Ultrasound
10.14.5 Mammography
10.15 Basis Point Share (BPS) Analysis by Technology
10.16 Absolute $ Opportunity Assessment by Technology
10.17 Market Attractiveness Analysis by Technology
Chapter 11 Europe Image-Guided Biopsy Analysis and Forecast
11.1 Introduction
11.2 Europe Image-Guided Biopsy Market Size Forecast by Country
11.2.1 Germany
11.2.2 France
11.2.3 Italy
11.2.4 U.K.
11.2.5 Spain
11.2.6 Russia
11.2.7 Rest of Europe
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Europe Image-Guided Biopsy Market Size Forecast by Process
11.6.1 Fine Needles
11.6.2 Core Needles
11.6.3 Vacuum-assisted Biopsy
11.7 Basis Point Share (BPS) Analysis by Process
11.8 Absolute $ Opportunity Assessment by Process
11.9 Market Attractiveness Analysis by Process
11.10 Europe Image-Guided Biopsy Market Size Forecast by End User
11.10.1 Ambulatory Surgery Centers
11.10.2 Clinics
11.10.3 Academic Institutes
11.10.4 Research
11.10.5 Hospitals
11.11 Basis Point Share (BPS) Analysis by End User
11.12 Absolute $ Opportunity Assessment by End User
11.13 Market Attractiveness Analysis by End User
11.14 Europe Image-Guided Biopsy Market Size Forecast by Technology
11.14.1 X- Ray
11.14.2 CT
11.14.3 MRI
11.14.4 Ultrasound
11.14.5 Mammography
11.15 Basis Point Share (BPS) Analysis by Technology
11.16 Absolute $ Opportunity Assessment by Technology
11.17 Market Attractiveness Analysis by Technology
Chapter 12 Asia Pacific Image-Guided Biopsy Analysis and Forecast
12.1 Introduction
12.2 Asia Pacific Image-Guided Biopsy Market Size Forecast by Country
12.2.1 China
12.2.2 Japan
12.2.3 South Korea
12.2.4 India
12.2.5 Australia
12.2.6 South East Asia (SEA)
12.2.7 Rest of Asia Pacific (APAC)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Asia Pacific Image-Guided Biopsy Market Size Forecast by Process
12.6.1 Fine Needles
12.6.2 Core Needles
12.6.3 Vacuum-assisted Biopsy
12.7 Basis Point Share (BPS) Analysis by Process
12.8 Absolute $ Opportunity Assessment by Process
12.9 Market Attractiveness Analysis by Process
12.10 Asia Pacific Image-Guided Biopsy Market Size Forecast by End User
12.10.1 Ambulatory Surgery Centers
12.10.2 Clinics
12.10.3 Academic Institutes
12.10.4 Research
12.10.5 Hospitals
12.11 Basis Point Share (BPS) Analysis by End User
12.12 Absolute $ Opportunity Assessment by End User
12.13 Market Attractiveness Analysis by End User
12.14 Asia Pacific Image-Guided Biopsy Market Size Forecast by Technology
12.14.1 X- Ray
12.14.2 CT
12.14.3 MRI
12.14.4 Ultrasound
12.14.5 Mammography
12.15 Basis Point Share (BPS) Analysis by Technology
12.16 Absolute $ Opportunity Assessment by Technology
12.17 Market Attractiveness Analysis by Technology
Chapter 13 Latin America Image-Guided Biopsy Analysis and Forecast
13.1 Introduction
13.2 Latin America Image-Guided Biopsy Market Size Forecast by Country
13.2.1 Brazil
13.2.2 Mexico
13.2.3 Rest of Latin America (LATAM)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Latin America Image-Guided Biopsy Market Size Forecast by Process
13.6.1 Fine Needles
13.6.2 Core Needles
13.6.3 Vacuum-assisted Biopsy
13.7 Basis Point Share (BPS) Analysis by Process
13.8 Absolute $ Opportunity Assessment by Process
13.9 Market Attractiveness Analysis by Process
13.10 Latin America Image-Guided Biopsy Market Size Forecast by End User
13.10.1 Ambulatory Surgery Centers
13.10.2 Clinics
13.10.3 Academic Institutes
13.10.4 Research
13.10.5 Hospitals
13.11 Basis Point Share (BPS) Analysis by End User
13.12 Absolute $ Opportunity Assessment by End User
13.13 Market Attractiveness Analysis by End User
13.14 Latin America Image-Guided Biopsy Market Size Forecast by Technology
13.14.1 X- Ray
13.14.2 CT
13.14.3 MRI
13.14.4 Ultrasound
13.14.5 Mammography
13.15 Basis Point Share (BPS) Analysis by Technology
13.16 Absolute $ Opportunity Assessment by Technology
13.17 Market Attractiveness Analysis by Technology
Chapter 14 Middle East & Africa (MEA) Image-Guided Biopsy Analysis and Forecast
14.1 Introduction
14.2 Middle East & Africa (MEA) Image-Guided Biopsy Market Size Forecast by Country
14.2.1 Saudi Arabia
14.2.2 South Africa
14.2.3 UAE
14.2.4 Rest of Middle East & Africa (MEA)
14.3 Basis Point Share (BPS) Analysis by Country
14.4 Absolute $ Opportunity Assessment by Country
14.5 Market Attractiveness Analysis by Country
14.6 Middle East & Africa (MEA) Image-Guided Biopsy Market Size Forecast by Process
14.6.1 Fine Needles
14.6.2 Core Needles
14.6.3 Vacuum-assisted Biopsy
14.7 Basis Point Share (BPS) Analysis by Process
14.8 Absolute $ Opportunity Assessment by Process
14.9 Market Attractiveness Analysis by Process
14.10 Middle East & Africa (MEA) Image-Guided Biopsy Market Size Forecast by End User
14.10.1 Ambulatory Surgery Centers
14.10.2 Clinics
14.10.3 Academic Institutes
14.10.4 Research
14.10.5 Hospitals
14.11 Basis Point Share (BPS) Analysis by End User
14.12 Absolute $ Opportunity Assessment by End User
14.13 Market Attractiveness Analysis by End User
14.14 Middle East & Africa (MEA) Image-Guided Biopsy Market Size Forecast by Technology
14.14.1 X- Ray
14.14.2 CT
14.14.3 MRI
14.14.4 Ultrasound
14.14.5 Mammography
14.15 Basis Point Share (BPS) Analysis by Technology
14.16 Absolute $ Opportunity Assessment by Technology
14.17 Market Attractiveness Analysis by Technology
Chapter 15 Competition Landscape
15.1 Image-Guided Biopsy Market: Competitive Dashboard
15.2 Global Image-Guided Biopsy Market: Market Share Analysis, 2019
15.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
15.3.1 Medtronic
15.3.2 Varian Medical Systems Inc.
15.3.3 Analogic Corporation
15.3.4 KARL STORZ Endoscopy India Pvt. Ltd.
15.3.5 Brainlab
15.3.6 Siemens Healthcare GmbH
15.3.7 Olympus Corporation
15.3.8 GENERAL ELECTRIC
15.3.9 Hologic Inc.
15.3.10 Koninklijke Philips N.V.
15.3.11 Stryker
Segments Covered in the Report
The global Image-Guided Biopsy market has been segmented based on
By Process
The global Image-Guided Biopsy market has been segmented based on
By Process
- Fine Needles
- Core Needles
- Vacuum-assisted Biopsy
- Ambulatory Surgery Centers
- Clinics
- Academic Institutes
- Research
- Hospitals
- X- Ray
- CT
- MRI
- Ultrasound
- Mammography
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- Medtronic
- Varian Medical Systems Inc.
- Analogic Corporation
- KARL STORZ Endoscopy India Pvt. Ltd.
- Brainlab
- Siemens Healthcare GmbH
- Olympus Corporation
- GENERAL ELECTRIC
- Hologic Inc.
- Koninklijke Philips N.V.
- Stryker
Our Clients
Related Reports
Some other reports from this category!
